Potentiator that Enhances Mucociliary Transport to Treat Cystic Fibrosis and other Mucus Obstructive Diseases

— Published date: 6/3/2026

Value Proposition: Using CLCA1 VWA to specifically potentiate TMEM16A to enhance mucociliary transport in cystic fibrosis and other mucus obstructive diseases.

Technology Description

Researchers at Washington University in St. Louis have developed a potentiator, CLCA1 …

Create a Collection
Creating...